PimedBio
-
ABOUT US
About Us
We create new treatments
based on cutting-edge approaches. -
PLATFORM
Platform
We create new treatments
based on cutting-edge approaches. -
PIPELINE
Pipeline
We create new treatments
based on cutting-edge approaches. - PR
-
CAREER
CAREER
We create new treatments
based on cutting-edge approaches.
Based on innovative scientific achievements,
Pimedbio's first-in-class drugs
Pimedbio's first-in-class drugs
- About Us
- History
History
Changing the standard of cancer treatment by bringing Korea’s 1st immune-oncology drug
2023
- 12
- 중소벤처기업부 해외마케팅 지원사업 선정
- 12
- 국가신약개발사업 347개 과제 중 10대 우수과제 선정
- 11
- KIT 기술사업화 투자촉진경진대회 동상 수상
- TEST
- TEST
2022
- 09
- 해외 10개국 특허 출원
- 08
- 국내 특허 등록 1건
- 06
- 중소기업기술혁신개발사업 시장확대형 지원사업 선정
- 03
- 국가신약개발사업 선도물질 지원사업 선정
2021
- 11
- 국가신약개발사업 비임상 지원사업 선정
2020
- 12
- Certified as a Inno-biz company
- 09
- Selected as a “TIPS start-up” with government grants
- 07
- Selected as a “BIG3 innovative company” with government grants
- 04
- Selected as a recipient of “One-Stop Supporting Grant” of government
2019
- 10
- VC funding
2018
- 11
- Certified as a “Venture Company” from government
- 01
- Selected as a recipient of “Biocore Facility Program Grant” of government
2017
- 04
- Received certification for “Qualified R&D Institute”
from government
- 03
- Established
